Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
OXYTETRACYCLINE DIHYDRATE
Zoetis Ireland Limited
QJ01AA06
OXYTETRACYCLINE DIHYDRATE
200 Mg/Ml
Solution for Injection
POM
Bovine, Deer, Ovine, Porcine
Oxytetracycline
Antibacterial
Authorised
2015-08-13
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Terramycin LA 200 mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE Oxytetracycline 200 mg as Oxytetracycline Dihydrate EXCIPIENTS Sodium formaldehyde-sulphoxylate dehydrate 2.2 mg For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear yellow to amber solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, Sheep, Pigs, Red Deer 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: For the treatment and control of pasteurellosis and pneumonia caused by oxytetracycline-sensitive organisms. May also be of value for the treatment of foul-in-the-foot. Pigs: For the treatment of pneumonia caused by _Pasteurella _spp. and the control of atrophic rhinitis. Sheep: For the control of enzootic abortion and pneumonia caused by oxytetracycline-sensitive organisms. Aid in the treatment of infectious ovine keratoconjunctivitis (pink-eye) and, in lambs, of tick-borne fever. May also be of value in the treatment of tick-pyaemia in lambs. Red-deer: Aid in the control of yersiniosis. 4.3 CONTRAINDICATIONS Not for use in ewes producing milk for human consumption. Do not use in animals with known hypersensitivity to the active ingredient. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 13/08/2015_ _CRN 7021015_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Not for use in ewes producing milk for human consumption. Not to be injected subcutaneously except in piglets under 10 kg bodyweight. Bacterial resistance may exist or develop after prolonged use of oxytetracycline. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRE Pročitajte cijeli dokument